http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PA-8589601-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-44
filingDate 2003-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75cc35ed92bb3647576b5086a76be295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8822834b9e3a806fa83b5eeb30670b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c61a0fb7a36e6bcfa7e16374de145f
publicationDate 2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PA-8589601-A1
titleOfInvention INDAZOL DERIVATIVES AS CRF ANTAGONISTS
abstract THIS INVENTION REFERS TO COMPOUNDS THAT ARE IN GENERAL ANTAGONISTS OF RECEIVERS OF THE CRF-1 FACTOR AND THAT FIT FORMULA IOA FORMULA II: IN WHICH R3 IS ARILO OR HETEROARILO EVENTUALLY REPLACED, R1 AND R2 HAVE THE MEANING IN THE DESCRIPTION ; OR INDIVIDUAL ISOMEROS, RACEMIC OR NON-RACEMIC MIXTURES OF ISOMEROS OR PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME. THE INVENTION REFERS IN ADDITION TO PROCESSES TO OBTAIN SUCH COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS FOR USE AS THERAPEUTIC AGENTS.
priorityDate 2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407608385

Total number of triples: 30.